Group 1: Company Overview - Premier, Inc. (PINC) shares increased by 9.7% to $28.25, with a notable trading volume, contrasting with a 2.4% gain over the past four weeks [1] - Premier has entered a definitive agreement to be acquired by Patient Square Capital, with stockholders set to receive $28.25 per share, reflecting a 23.8% premium to the 60-day volume-weighted average price as of September 5, 2025 [2] Group 2: Financial Performance Expectations - The upcoming quarterly earnings for Premier are projected at $0.28 per share, indicating a year-over-year decline of 17.7%, with revenues expected to be $239.23 million, down 3.6% from the previous year [3] - The consensus EPS estimate for Premier has been revised down by 10.4% over the last 30 days, suggesting a negative trend in earnings estimate revisions, which typically does not lead to price appreciation [4] Group 3: Industry Context - Premier operates within the Zacks Medical Services industry, where another company, Ascend Wellness Holdings, Inc. (AAWH), saw a 6.1% decline in its stock price, with a return of -8.6% over the past month [4] - Ascend Wellness Holdings' consensus EPS estimate has decreased by 15.4% over the past month to -$0.1, representing a year-over-year change of +23.1%, and it currently holds a Zacks Rank of 4 (Sell) [5]

Group 1 - U.S. stocks showed mixed performance, with the Dow Jones index declining over 100 points on Monday [1] - PROS Holdings, Inc. shares surged 40% to $22.97 following the announcement of its acquisition by Thoma Bravo [1] - MBX Biosciences, Inc. saw a significant increase of 144% to $24.40 after its once-weekly Canvuparatide met primary endpoints in a Phase 2 trial [3] - Metsera, Inc. gained 62.8% to $54.25 amid reports of a near acquisition deal with Pfizer [3] - Anywhere Real Estate Inc. experienced a 57% rise to $11.13 due to a combination announcement with Compass in an all-stock transaction [3] - The ODP Corporation's shares increased by 33.6% to $27.82 after announcing a definitive agreement to be acquired by an affiliate of Atlas Holdings [3] - Banco BBVA Argentina S.A. shares rose 17.7% to $9.64 following U.S. Treasury Secretary Bessent's statement of support for Argentina [3] - Grupo Supervielle S.A. also saw a 16% increase to $5.83 under similar circumstances regarding U.S. support for Argentina [3] - Lumen Technologies, Inc. rose 12.5% to $6.43 after announcing significant progress in building infrastructure for the AI economy [3] - IREN Limited gained 10.7% to $42.88 after doubling its AI Cloud capacity to 23,000 GPUs [3]

MILWAUKEE , Sept. 22, 2025 /PRNewswire/ -- The Ademi Firm is investigating Premier (Nasdaq: PINC) for possible breaches of fiduciary duty and other violations of law in its transaction with Patient Square Capital. ...

Premier Inc. (NASDAQ:PINC) said Monday it will be acquired by an affiliate of Patient Square Capital in a deal valued at $28.25 per share in cash. The agreement, unanimously approved by Premier’s board, gives shareholders a 23.8% premium to the company’s 60-day average closing price as of Sept. 5, 2025. Board chair Richard Statuto said the sale will provide “immediate and certain value” to investors while giving the company more capital to expand services during a pivotal moment in U.S. health care. Also ...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Premier, Inc. (NASDAQ: PINC) to an affiliate of Patient Square Capital for $28.25 in cash per share is fair to Premier shareholders. Halper Sadeh encourages Premier shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns wheth. ...

Group 1 - Premier has entered into a definitive agreement to be acquired by an affiliate of Patient Square Capital [1] - The acquisition has been unanimously approved by Premier's board of directors [1] - Premier stockholders will receive $28.25 in cash per share as part of the acquisition [1]

Core Viewpoint - Premier, Inc. has entered into a definitive agreement to be acquired by an affiliate of Patient Square Capital, with stockholders set to receive $28.25 in cash per share, reflecting a 23.8% premium to the current share price [1] Company Summary - Premier, Inc. is described as a leading technology-driven health care improvement company [1] - The acquisition agreement has received unanimous approval from Premier's Board of Directors [1]

Group 1 - Nuclear Fuels Inc. has completed the arrangement where Premier American Uranium Inc. acquired all issued and outstanding common shares of Nuclear Fuels, resulting in Nuclear Fuels becoming a wholly owned subsidiary of Premier American Uranium [1][3] - As part of the arrangement, Nuclear Fuels shareholders received 0.33 of a common share of Premier American Uranium for each share of Nuclear Fuels held, totaling 32,521,748 shares issued by Premier American Uranium [2][4] - Nuclear Fuels Inc. will be delisted from the market at the close of trading on September 16, 2025 [2][4]

Core Insights - Premier, Inc. has announced a five-year group purchasing agreement with Premier Infusion and Healthcare Services, Inc. [1] Company Overview - Premier, Inc. is a technology-enabled healthcare performance improvement company [1] - Premier Infusion and HCS is a closed-door infusion pharmacy based in Torrance, California [1] Service Coverage - Premier Infusion and HCS serves all counties in California as well as Arizona, Colorado, Idaho, Illinois, Nevada, and Washington [1]

Core Viewpoint - Premier American Uranium Inc. has successfully completed the acquisition of Nuclear Fuels Inc., making it a wholly owned subsidiary, which enhances its exploration portfolio in the U.S. uranium sector [1][2][3]. Acquisition Details - The arrangement involved Premier American Uranium acquiring 100% of the outstanding common shares of Nuclear Fuels, with shareholders receiving 0.33 of a PUR share for each NF share held, totaling 32,521,748 PUR shares issued [2][4]. - The NF shares are expected to be delisted from the Canadian Securities Exchange on September 16, 2025, and Nuclear Fuels will apply to cease being a reporting issuer [4][6]. Strategic Implications - The acquisition strengthens Premier American Uranium's position in the Powder River uranium district, joining major landholders like Cameco Corporation and Energy Fuels Inc. [3][10]. - The company aims to consolidate, explore, and develop uranium projects across the U.S., focusing on enhancing domestic energy security and transitioning to clean energy [10][11]. Management Changes - Following the acquisition, the board of directors of Premier American Uranium has expanded to seven members, incorporating individuals from Nuclear Fuels, while the senior management team remains unchanged [5][6]. Financial Advisory - Haywood Securities Inc. served as the financial advisor for the arrangement, receiving 138,942 PUR shares as part of their compensation [9].